Roidipedia.Compound reference & reporting
05 AUG 2026
CompoundsPharmaceutical Minoxidil
PharmaceuticalVasodilatorPotassium-channel openerHair-growth agent

Minoxidil

Also known as Rogaine · Regaine · LDOM (low-dose oral minoxidil)

Minoxidil is a vasodilator repurposed as the leading topical hair-loss treatment, also used off-label at low oral doses. It is not an anti-androgen but is the standard companion to 5ARIs and AR antagonists, promoting hair growth by prolonging the follicle growth phase. Oral use adds cardiovascular and fluid-retention considerations.

01 Overview

Originally an oral antihypertensive, minoxidil's hair-growth side effect led to topical formulations (Rogaine) approved for androgenetic alopecia in both sexes. In recent years low-dose oral minoxidil (LDOM) has become popular off-label for greater convenience and efficacy.

Topical minoxidil is well tolerated aside from local irritation and unwanted facial hair; oral use requires attention to blood pressure, heart rate, and fluid retention. It is mechanistically complementary to DHT-blocking drugs and often combined with them.

02 Mechanism

As the active sulfated metabolite, minoxidil opens ATP-sensitive potassium channels and acts as a vasodilator, prolonging the anagen (growth) phase of hair follicles and enlarging miniaturised follicles; it does not affect androgens.

03 Dosing

TierDoseRouteNotes
Low-dose oral (off-label)0.625–5 mg/dayOralLDOM 0.625-5 mg/day off-label for hair loss
Topical2–5 %/dayTransdermal5% foam/solution once or twice daily to the scalp

04 Effects

EffectMagnitudeEvidence
Increased hair growthIncreases hair count and thickness in androgenetic alopecia; prolongs the growth phase.Significant vs placeboClinical
Synergy with anti-androgensComplements finasteride/dutasteride by acting through a non-hormonal mechanism.AdditiveClinical

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Unwanted facial/body hair (hypertrichosis)Excess hair growth on the face or elsewhere, more common with oral use.MildCommonClinical
Fluid retention / edema (oral)Ankle swelling and fluid retention, mainly with oral dosing.ModerateUncommonClinical
Tachycardia / palpitations (oral)Increased heart rate or palpitations with oral use.ModerateUncommonClinical

07 References

Low-dose oral minoxidil for the treatment of androgenetic alopeciaJournal of the American Academy of Dermatology, 2021

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.